Equity Analysts Changed These Share Price Targets Today

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on February 14th:

United Therapeutics (NASDAQ:UTHR): Reports Q4 revenue $195.2M vs. consensus $204.81M

Brean Murray reiterated its rating of Buy for this company and changed its price target from $55 to $57.

Cutera (NASDAQ:CUTR):

Maxim Group reiterated its rating of Buy for this company and changed its price target from $9 to $10.

Westamerica Banc (NASDAQ:WABC):

RBC Capital Mkts reiterated its rating of Sector Perform for this company and changed its price target from $46 to $50.

Textron (NYSE:TXT):

RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $28 to $32.

Regeneron Pharms (NASDAQ:REGN): Trading at more than 20x sales, Regeneron (NASDAQ:REGN) is no bargain. For Regeneron’s stock price to keep moving higher, Eylea sales will likely have to keep beating expectations. Also the company will likely have to deliver a steady stream of good news regarding drug candidates in its pipeline, Barron’s says. Regeneron isn’t expected to turn a profit until 2014.

RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $83 to $130.

Rackspace (NYSE:RAX):

Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $50 to $66.

Ultra Clean Holdings (NASDAQ:UCTT):

Needham reiterated its rating of Buy for this company and changed its price target from $9 to $10.

AsiaInfo (NASDAQ:ASIA):

BMO Capital Markets reiterated its rating of Market Perform for this company and changed its price target from $10 to $12.

Regal Entertainment (NYSE:RGC):

Wunderlich reiterated its rating of Buy for this company and changed its price target from $19 to $22.

Transocean (NYSE:RIG):

HSBC Securities reiterated its rating of Overweight for this company and changed its price target from $73 to $76.

Mattel (NASDAQ:MAT):

Longbow reiterated its rating of Buy for this company and changed its price target from $32 to $37.

KVH Industries (NASDAQ:KVHI):

Needham reiterated its rating of Buy for this company and changed its price target from $10 to $12.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Wall St. Cheat Sheet Staff at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com